Physician profile
Patrick Chizek
NPI 1245790294
$7,717.75
in general payments reported to CMS, 2019-2025
11 companies · $7,057 in 2025
The $7,057 reported for 2025 was more than what 91% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.29 · 2024: $605 · 2025: $7,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,741 · Travel and Lodging: $1,128 · Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,741.39 |
| Travel and Lodging | $1,128.20 |
| Food and Beverage | $848.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,665.75 | 2023-2025 | |
| Applied Medical Resources Corporation | $852.55 | 2024-2025 | Gelport Laparoscopic System |
| Medtronic, INC. | $629.84 | 2024-2025 | Interstim |
| Stryker Corporation | $241.39 | 2025 | |
| Boston Scientific Corporation | $97.41 | 2025 | General - Hemostasis |
| Takeda Pharmaceuticals U.S.A., INC. | $66.14 | 2025 | Eohilia, Gattex, Entyvio |
| Bolton Medical INC | $57.16 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Abbvie INC. | $36.21 | 2025 | |
| Aimmune Therapeutics, INC. | $30.60 | 2025 | Zenpep |
| Regeneron Healthcare Solutions, INC. | $27.23 | 2025 | Dupixent |
| Ardelyx, INC. | $13.47 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Chizek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.